AdaptHealth Corp. (NASDAQ:AHCO) Shares Purchased by Nuveen Asset Management LLC

Nuveen Asset Management LLC lifted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 27.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 316,108 shares of the company's stock after acquiring an additional 69,050 shares during the period. Nuveen Asset Management LLC owned approximately 0.23% of AdaptHealth worth $3,009,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Assetmark Inc. purchased a new stake in AdaptHealth in the fourth quarter valued at approximately $28,000. Blue Trust Inc. boosted its position in AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after buying an additional 1,115 shares during the last quarter. Guggenheim Capital LLC boosted its position in AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after buying an additional 1,525 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in AdaptHealth in the fourth quarter valued at approximately $169,000. Finally, Humankind Investments LLC lifted its holdings in AdaptHealth by 18.3% in the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock valued at $171,000 after acquiring an additional 2,776 shares during the period. Hedge funds and other institutional investors own 82.67% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on AHCO. Truist Financial decreased their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Robert W. Baird boosted their price target on AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Royal Bank of Canada cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. UBS Group cut their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Finally, Canaccord Genuity Group boosted their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Price Performance

Shares of AdaptHealth stock remained flat at $8.86 during trading hours on Wednesday. 688,230 shares of the stock were exchanged, compared to its average volume of 1,287,289. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The stock has a market capitalization of $1.20 billion, a P/E ratio of -5.37, a P/E/G ratio of 1.08 and a beta of 1.64. The firm has a 50-day moving average price of $8.90 and a two-hundred day moving average price of $9.58. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.